Treatment of depression in Parkinson's disease: a meta-analysis.

Author: KlaassenT, RozendaalN, SneijdersG H, VerheyF R, de VetH C, van PraagH M

Paper Details 
Original Abstract of the Article :
Despite a 40% prevalence of depression in idiopathic Parkinson's disease (PD), an extensive literature search found only 12 controlled studies of treatment efficacy. A meta-analysis of these was performed in pursuit of guidelines for pharmacological treatment. Articles were scored on a scale from 0 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1176/jnp.7.3.281

データ提供:米国国立医学図書館(NLM)

Treating Depression in Parkinson's Disease: A Meta-Analysis

This research navigates the intricate desert of [Parkinson's disease (PD)] and the associated challenge of [depression], a common comorbidity that significantly impacts quality of life. The authors conducted a meta-analysis of controlled studies to assess the efficacy of [pharmacological treatment] for depression in individuals with PD. It's like a camel caravan seeking a solution to the challenging sandstorms of [depression] that often accompany the journey of [PD].

Limited Evidence for Pharmacological Treatment of Depression in PD

The meta-analysis revealed a [lack of robust evidence] supporting the use of [pharmacological interventions] to treat [depression] in PD. This underscores the need for [further research] in this area to develop effective treatment strategies. It's like searching for a well-hidden oasis of [effective treatments] within the vast desert of [PD and depression], requiring persistent exploration and careful investigation.

The Need for More Research

The findings highlight the importance of [clinical trials] to evaluate the efficacy of different treatment options for [depression] in PD. This research is crucial for improving patient care and gaining a deeper understanding of the complex interplay between these two conditions. It's like a team of explorers venturing into a vast and unknown desert, seeking to chart a new course towards [improved health and well-being] for individuals with PD and depression.

Dr. Camel's Conclusion

This research emphasizes the need for further investigation into effective treatments for depression in Parkinson's disease. The lack of robust evidence highlights the importance of continued research to improve the lives of individuals facing this challenging comorbidity.

Date :
  1. Date Completed 1995-12-06
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

7580184

DOI: Digital Object Identifier

10.1176/jnp.7.3.281

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.